The Monoclonal Antibody Therapy Market is on a trajectory toward unprecedented growth, with projections indicating a market size of USD 232.1 billion by 2035. This significant escalation represents a compound annual growth rate (CAGR) of 3.97% from a current size of USD 151.25 billion in 2024. With increasing investments in biotechnology and personalized medicine, the focus on monoclonal...

According to a new report from Intel Market Research, the global Pembrolizumab market was valued at USD 21.8 billion in 2025 and is projected to grow from USD 24.3 billion in 2026 to USD 42.7 billion by 2034, exhibiting a robust CAGR of 7.3% during the forecast period. This growth is driven by increasing cancer prevalence, rising immunotherapy adoption, expanding regulatory approvals for new...